Director, Financial Planning and Analysis

Attention recruitment agencies: All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on any requisition. Agencies contacting hiring managers directly will not be tolerated, and doing so may impact your ability to work with 4DMT in the future. 4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) with a single, safe, intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company’s lead indication for 4D-150 is wet age-related macular degeneration, which is currently in Phase 3 development, and second indication is diabetic macular edema. The Company’s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery GENERAL SUMMARY The Director, FP&A – TechOps serves as the primary finance business partner to the TechOps organization, providing end‑to‑end financial leadership across Manufacturing, Supply Chain, CMC Quality, and External Manufacturing as 4DMT transitions from late‑stage clinical development to commercial readiness and launch. This role is responsible for driving financial planning, forecasting, and decision support for a rapidly scaling TechOps organization. The Director will partner closely with TechOps leadership to translate operational plans into clear financial outcomes, proactively manage risks, and enable disciplined, data‑driven decisions. The position is expected to operate as a hands‑on, strategic individual contributor, with future people management potential as the organization scales. The Director role will report to the CFO and is expected on site MAJOR DUTIES & RESPONSIBILITIES: Act as the primary finance partner to TechOps leadership, supporting strategic planning, operational decisions, and investment prioritization Translate TechOps strategy, timelines, and operating plans into financial forecasts with implications, trade‑offs, and scenarios Own the TechOps annual budget, rolling forecast, and long‑range plan inputs through close coordination with business partners Develop and maintain detailed spend, headcount, and models aligned to clinical needs, manufacturing runs and launch timelines Ensure financial plans accurately reflect changes in demand, supply constraints, tech transfers, and scale‑up activities Lead scenario and sensitivity analyses to assess financial impact of operational risks and strategic alternatives. Deliver clear monthly variance analysis, forecasting updates, and KPI reporting for TechOps leadership and Finance. Support company‑wide cash flow forecasting and runway modeling, with particular focus on timelines and spend phasing QUALIFICATIONS: Education: Bachelor's degree in Accounting, Finance, or related field; CPA or MBA preferred Experience: 10+ years of progressive experience in FP&A roles Prior biotech, pharmaceutical, or life sciences experience required Experience supporting a late‑stage clinical development organization through commercial launch (ideally first global product launch) required Experience with ERP selection and implementation Direct experience partnering with TechOps, Manufacturing, Supply Chain, and/or CMC organizations required Understanding of CMC processes (e.g. upstream, downstream, fill finish, pack and label, etc) Experience partnering with Clinical Development is a plus Skills: Proficiency in finance software (e.g., NetSuit